A Randomized, Double-Blind, Crossover Study to Investigate the Pharmacokinetics of Extended-Release Melatonin Compared to Immediate-Release Melatonin in Healthy Adults

References

• Beck F, Léger D, Fressard L, Peretti-Watel P, Verger P, The Coconel Group. 2021. Covid-19 health crisis and lockdown associated with high level of sleep complaints and hypnotic uptake at the population level. J Sleep Res. 30(1):e13119. doi:10.1111/jsr.13119.
   PubMed Web of Science ®Google Scholar
• Besedovsky L, Lange T, Haack M. 2019. The sleep-immune crosstalk in health and disease. Physiol Rev. 99(3):1325–1380. doi:10.1152/physrev.00010.2018.
   PubMed Web of Science ®Google Scholar
• Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova IV, Ben-Shushan A, Ford I. 2005. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev. 9(1):41–50. doi:10.1016/j.smrv.2004.06.004.
   PubMed Web of Science ®Google Scholar
• Bubenik GA, Konturek SJ. 2011. Melatonin and aging: prospects for human treatment. J Physiol Pharmacol. 62(1):13–19.
   PubMed Web of Science ®Google Scholar
• Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S. 2005. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med. 20(12):1151–1158. doi:10.1111/j.1525-1497.2005.0243.x.
   PubMed Web of Science ®Google Scholar
• Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. 2011. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 32(12):1484–1492. doi:10.1093/eurheartj/ehr007.
   PubMed Web of Science ®Google Scholar
• Cardinali DP, Vigo DE, Olivar N, Vidal MF, Furio AM, Brusco LI. 2012. Therapeutic application of melatonin in mild cognitive impairment. Am J Neurodegener Dis. 1(3):280–291.
   PubMedGoogle Scholar
• Cavallo A, Ritschel WA. 1996. Pharmacokinetics of melatonin in human sexual maturation. J Clin Endocrinol Metab. 81(5):1882–1886. doi:10.1210/jcem.81.5.8626852.
   PubMed Web of Science ®Google Scholar
• Cepeda MS, Stang P, Blacketer C, Kent JM, Wittenberg GM. 2016. Clinical relevance of sleep duration: Results from a cross-sectional analysis using NHANES. J Clin Sleep Med. 12(6):813–819. doi:10.5664/jcsm.5876.
   PubMed Web of Science ®Google Scholar
• Chaput JP, Despres JP, Bouchard C, Tremblay A. 2007. Association of sleep duration with type 2 diabetes and impaired glucose tolerance. Diabetologia. 50(11):2298–2304. doi:10.1007/s00125-007-0786-x.
   PubMed Web of Science ®Google Scholar
• Chattu VK, Manzar MD, Kumary S, Burman D, Spence DW, Pandi-Perumal SR. 2018. The global problem of insufficient sleep and its serious public health implications. Healthcare (Basel). 7(1):1. doi:10.3390/healthcare7010001.
   PubMedGoogle Scholar
• Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ, Deng MH. 1994. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci U S A. 91(5):1824–1828. doi:10.1073/pnas.91.5.1824.
   PubMed Web of Science ®Google Scholar
• European Medical Agency. 2007. Circadin: EPAR Assessment Report. EMEA; https://www.ema.europa.eu/en/medicines/human/EPAR/circadin.
   Google Scholar
• Ferracioli-Oda E, Qawasmi A, Bloch MH. 2013. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 8(5):e63773. doi:10.1371/journal.pone.0063773.
   PubMed Web of Science ®Google Scholar
• Fourtillan JB, Brisson AM, Fourtillan M, Ingrand I, Decourt JP, Girault J. 2001. Melatonin secretion occurs at a constant rate in both young and older men and women. Am J Physiol Endocrinol Metab. 280(1):E11–22. doi:10.1152/ajpendo.2001.280.1.E11.
   PubMed Web of Science ®Google Scholar
• Gooneratne NS, Edwards AY, Zhou C, Cuellar N, Grandner MA, Barrett JS. 2012. Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults. J Pineal Res. 52(4):437–445. doi:10.1111/j.1600-079X.2011.00958.x.
   PubMed Web of Science ®Google Scholar
• Grandner MA, Schopfer EA, Sands-Lincoln M, Jackson N, Malhotra A. 2015. Relationship between sleep duration and body mass index depends on age. Obesity (Silver Spring). 23(12):2491–2498. doi:10.1002/oby.21247.
   PubMed Web of Science ®Google Scholar
• Harpsoe NG, Andersen LP, Gogenur I, Rosenberg J. 2015. Clinical pharmacokinetics of melatonin: a systematic review. Eur J Clin Pharmacol. 71(8):901–909. doi:10.1007/s00228-015-1873-4.
   PubMed Web of Science ®Google Scholar
• Herxheimer AD, Petrie KJ. 2002. Melatonin for the prevention and treatment of jet lag (Review). The Cochrane Collab. 2.
   Google Scholar
• Hirshkowitz M, Whiton K, Albert SM, Alessi C, Bruni O, DonCarlos L, Hazen N, Herman J, Katz ES, Kheirandish-Gozal L, et al. 2015. National Sleep Foundation’s sleep time duration recommendations: methodology and results summary. Sleep Health. 1(1):40–43. doi:10.1016/j.sleh.2014.12.010.
   PubMed Web of Science ®Google Scholar
• Irwin MR. 2015. Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol. 66:143–172. doi:10.1146/annurev-psych-010213-115205.
   PubMed Web of Science ®Google Scholar
• Karasek M. 2004. Melatonin, human aging, and age-related diseases. Exp Gerontol. 39(11-12):1723–1729. doi:10.1016/j.exger.2004.04.012.
   PubMed Web of Science ®Google Scholar
• Kripke DF. 2016. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Res. 5:918. doi:10.12688/f1000research.8729.1.
   PubMedGoogle Scholar
• Lemoine P, Garfinkel D, Laudon M, Nir T, Zisapel N. 2011. Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal. Ther Clin Risk Manag. 7:301–311. doi:10.2147/TCRM.S23036.
   PubMed Web of Science ®Google Scholar
• Lemoine P, Nir T, Laudon M, Zisapel N. 2007. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res. 16(4):372–380. doi:10.1111/j.1365-2869.2007.00613.x.
   PubMed Web of Science ®Google Scholar
• Lemoine P, Zisapel N. 2012. Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia. Expert Opin Pharmacother. 13(6):895–905. doi:10.1517/14656566.2012.667076.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wheaton AG, Chapman DP, Cunningham TJ, Lu H, Croft JB. 2016. Prevalence of healthy sleep duration among adults–United States, 2014. MMWR Morb Mortal Wkly Rep. 65(6):137–141. doi:10.15585/mmwr.mm6506a1.
   PubMed Web of Science ®Google Scholar
• López-Gamboa M, Canales-Gómez JS, Sandoval TJC, Tovar EN, Mejía MA, Baltazar MAM, Palma-Aguirre J. 2010. Bioavailability of long acting capsules of melatonin in Mexican healthy volunteers. J Bioequiv Availab. 2(5):116–119.
   Google Scholar
• Mandelkorn U, Genzer S, Choshen-Hillel S, Reiter J, Meira ECM, Hochner H, Kheirandish-Gozal L, Gozal D, Gileles-Hillel A. 2020. Escalation of sleep disturbances amid the COVID-19 pandemic: a cross-sectional international study. J Clin Sleep Med.
   Web of Science ®Google Scholar
• Mangoni AA, Jackson SH. 2004. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 57(1):6–14. doi:10.1046/j.1365-2125.2003.02007.x.
   PubMed Web of Science ®Google Scholar
• Paruthi S, Brooks LJ, D'Ambrosio C, Hall WA, Kotagal S, Lloyd RM, Malow BA, Maski K, Nichols C, Quan SF, et al. 2016. Consensus statement of the American academy of sleep medicine on the recommended amount of sleep for healthy children: methodology and discussion. J Clin Sleep Med. 12(11):1549–1561. doi:10.5664/jcsm.6288.
   PubMed Web of Science ®Google Scholar
• Seixas AA, Vallon J, Barnes-Grant A, Butler M, Langford AT, Grandner MA, Schneeberger AR, Huthchinson J, Zizi F, Jean-Louis G. 2018. Mediating effects of body mass index, physical activity, and emotional distress on the relationship between short sleep and cardiovascular disease. Medicine (Baltimore). 97(37):e11939. doi:10.1097/MD.0000000000011939.
   PubMed Web of Science ®Google Scholar
• Sharma M, Palacios-Bois J, Schwartz G, Iskandar H, Thakur M, Quirion R, Nair NP. 1989. Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry. 25(3):305–319. doi:10.1016/0006-3223(89)90178-9.
   PubMed Web of Science ®Google Scholar
• Stamatakis KA, Brownson RC. 2008. Sleep duration and obesity-related risk factors in the rural Midwest. Prev Med. 46(5):439–444. doi:10.1016/j.ypmed.2007.11.008.
   PubMed Web of Science ®Google Scholar
• Sun H, Gusdon AM, Qu S. 2016. Effects of melatonin on cardiovascular diseases: progress in the past year. Curr Opin Lipidol. 27(4):408–413. doi:10.1097/MOL.0000000000000314.
   PubMed Web of Science ®Google Scholar
• Tobaldini E, Fiorelli EM, Solbiati M, Costantino G, Nobili L, Montano N. 2019. Short sleep duration and cardiometabolic risk: from pathophysiology to clinical evidence. Nat Rev Cardiol. 16(4):213–224. doi:10.1038/s41569-018-0109-6.
   PubMed Web of Science ®Google Scholar
• Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N. 2011. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response. Curr Med Res Opin. 27(1):87–98. doi:10.1185/03007995.2010.537317.
   PubMed Web of Science ®Google Scholar
• Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, Frydman-Marom A, Zisapel N. 2014. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial. Clin Interv Aging. 9:947–961. doi:10.2147/CIA.S65625.
   PubMed Web of Science ®Google Scholar
• Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N. 2007. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Curr Med Res Opin. 23(10):2597–2605. doi:10.1185/030079907X233098.
   PubMed Web of Science ®Google Scholar
• Zhdanova IV, Wurtman RJ, Balcioglu A, Kartashov AI, Lynch HJ. 1998. Endogenous melatonin levels and the fate of exogenous melatonin: age effects. J Gerontol A Biol Sci Med Sci. 53(4):B293–298. doi:10.1093/gerona/53a.4.b293.
   PubMed Web of Science ®Google Scholar
• Zhdanova IV, Wurtman RJ, Morabito C, Piotrovska VR, Lynch HJ. 1996. Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans. Sleep. 19(5):423–431. doi:10.1093/sleep/19.5.423.
   PubMed Web of Science ®Google Scholar